Joseph L. Damasio, Jr.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Joseph L. Damasio, Jr.
Joseph L. Damasio, Jr. is recorded as CFO at Harvard Apparatus Regenerative Technology, Inc. (HRGN). Harvard Apparatus Regenerative Technology, Inc. reported in an 8-K filed August 10, 2022 that Joseph L. Damasio, Jr. was appointed Chief Financial Officer, effective August 8, 2022.
“Effective as of August 8, 2022, Biostage, Inc. (the Company) appointed Joseph L. Damasio, Jr., as Chief Financial Officer.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2022-08-08–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Harvard Apparatus Regenerative Technology, Inc.
Other people whose current roles at this company are on record from its filings.
- David Green CEO, Chairman, Board Member
- Junli (Jerry) He CEO, Chairman
- James Mastridge CFO, Chief Accounting Officer
- Joseph Damasio CFO
- Peter Chakoutis CFO
- Thomas McNaughton CFO
- Class I Directors Board Member
- Class III Directors Board Member
- James Shmerling Board Member
- Jerry He Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.